MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,712 | -28.4% | 7,411 | -24.9% | 0.08% | -33.6% |
| Q1 2023 | $2,390 | -4.8% | 9,867 | +14.1% | 0.11% | -18.7% |
| Q4 2022 | $2,511 | -99.6% | 8,650 | -6.4% | 0.14% | +286.1% |
| Q3 2022 | $601,000 | +74.2% | 9,240 | +91.6% | 0.04% | +38.5% |
| Q2 2022 | $345,000 | -27.1% | 4,823 | 0.0% | 0.03% | -16.1% |
| Q1 2022 | $473,000 | +3.3% | 4,823 | -10.8% | 0.03% | -45.6% |
| Q4 2021 | $458,000 | – | 5,409 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |